Skip to content

Trial Objectives


The purpose of this study is to better understand lung diseases that develop from inhaling mineral dust over time.

Although the causes of diseases such as "black lung" and silicosis are known, it is not well understood why some people get these diseases and others don't or how stopping exposure to mineral dust may affect the severity of these diseases. This study will be conducted through phone interviews with participants. The information our researchers collect will be used to learn more about lung diseases with workplace exposure to mineral dusts.

Who Can Participate


Adults who have at least five years of United States based work as a miner or who have been exposed to mineral dusts at work such as silica and who have evidence of lung disease due to mineral dust exposures may be eligible to participate. Medical and work history, chest imaging, pulmonary function testing or any available lung tissue specimens will be collected and analyzed. Family members may donate the lung tissue of a deceased relative if it was saved at a hospital or other health care facility.

Age: 18+ Gender Any

Estimated Time Commitment


Not Specified

Time Commitment Details


A 45-minute phone call at beginning of study, with follow-up 30-minute phone interviews every three to five years thereafter.

Payment & Reimbursement


Payment Not Provided

Travel Reimbursement Not Available

Trial Contact


For more information, contact:

Lauren Zell-Baran
303.398.1187

 

Noah Lowen
303.398.1748

Request More Information

Trial Location


National Jewish Main Campus, Denver, CO

Trial Sponsors


National Jewish Health Division of Environmental and Occupational Health Sciences

Principal Investigators

Cecile S. Rose

Cecile S. Rose, MD, MPH

Co-Investigators

  • E Brigitte Gottschall

    E Brigitte Gottschall, MD

  • Silpa D. Krefft

    Silpa D. Krefft, MD, MPH

Request more Information

By completing this form, you agree to learn more about this study and see if you qualify.

I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health required